U.S. markets open in 6 hours 31 minutes
  • S&P Futures

    3,842.25
    +23.00 (+0.60%)
     
  • Dow Futures

    31,901.00
    +125.00 (+0.39%)
     
  • Nasdaq Futures

    12,446.00
    +148.75 (+1.21%)
     
  • Russell 2000 Futures

    2,212.90
    +12.10 (+0.55%)
     
  • Crude Oil

    64.53
    -0.52 (-0.80%)
     
  • Gold

    1,694.10
    +16.10 (+0.96%)
     
  • Silver

    25.53
    +0.26 (+1.03%)
     
  • EUR/USD

    1.1885
    +0.0032 (+0.27%)
     
  • 10-Yr Bond

    1.5960
    0.0000 (0.00%)
     
  • Vix

    25.47
    +0.81 (+3.28%)
     
  • GBP/USD

    1.3878
    +0.0056 (+0.40%)
     
  • USD/JPY

    108.8150
    -0.0860 (-0.08%)
     
  • BTC-USD

    53,729.91
    +3,402.04 (+6.76%)
     
  • CMC Crypto 200

    1,080.47
    +56.27 (+5.49%)
     
  • FTSE 100

    6,719.13
    +88.61 (+1.34%)
     
  • Nikkei 225

    29,027.94
    +284.69 (+0.99%)
     

U.S. replaces director of agency overseeing COVID-19 vaccines, drugs

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
By Julie Steenhuysen
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

By Julie Steenhuysen

CHICAGO, April 21 (Reuters) - The U.S. Department of Health and Human Services said on Tuesday it has replaced Rick Bright as director of a key U.S. agency charged with developing drugs and vaccines for COVID-19.

Bright, who was director of the Biomedical Advanced Research and Development Authority (BARDA) since 2016, has been moved to a new public-private partnership under the National Institutes of Health announced last week, according to a Health and Human Services representative. BARDA serves under the HHS Office of the Assistant Secretary for Preparedness and Response.

Under Bright's leadership, BARDA recently announced nearly $1 billion in support of vaccine manufacturing efforts by Moderna and Johnson & Johnson.

Bright, an expert in vaccines and therapeutics, will be replaced by Gary Disbrow, his former deputy, who will serve as acting director of BARDA. The change was first reported by STAT news. (Reporting by Julie Steenhuysen; editing by Jonathan Oatis)